Intellectual Property
Minneapolis/St. Paul
What is an Invention?
Factors That Make a Patent Valuable
Why Perform Risk Profile?
What is a Patent?
How can OSS Negatively Affect a Company?
Background
Patents and Other Forms of Intellectual Property Protection
Audit Action Sheet
What Do I Give up in Getting My Patent?
Inventorship
Prior Art Challenge
Trade Name Protection and Trademark Protection
Patent Trial and Appeal Board
Repeating Competitor Audits
The Five Components of an Open Source Software Policy
PTAB Final Argument Trial Dynamics
Golden Rule of Auditing a Patent Portfolio
Inventors and Patent Analytics
Infringement on the Rights of Other Patents
Cost of Registering a Trademark
Improving Patent Portfolio Value
Inventorship vs Ownership
Forms of Confidential Information
Secondary Meaning of a Trademark
What IP Should I Spend Money on First?
Picking a Domain Name
"How Much" - Audit Action Sheet
Should IP be Part of Our Business Plan?
Why Should Claims Not Be Read on the Prior Art?
Goal of a Value-Driven Patent Portfolio
NDAs and Customers
OSS Licensing Conditions
BioSimilar Patenting Litigation Involving Large Amounts of Money
Auction Audit Sheet - Key Issues to Address
Prior Art and Rejections
The Different Types of Marks
Rewards of the Practice
ITU
Importance of Getting a Patent
Open Source Software
Marking a Product
Third Party Confidentiality
Picking a Trademark
"SM" Symbol
What Doesn't a Patent Provide?
Implementing a Value-Driven Portfolio Process
Experience
Intellectual Property Protection
Date of First Use
Refused Trademark Recourse
FDA Guidelines for Demonstrating Biosimilarity
High Risk Joint Ventures
Infringing on Another Patent
Considerations Before Hiring IP Council
Provisional vs Non-Provisional Patent
How Long Does an FTO Take?
Trademarks and Brand Value
How to Navigate BioSimilar Challenges
Risks of Not Patenting
"Claims" of a Patent
Budgeting for Drafting and Prosecution
Freedom To Operate vs Clearance
Challenges When Dealing with Patent Matters
Copyright
Value-Driven Patent Portfolio
A Better Way to Allocate Patent Application Budgets
When to Do a Freedom to Operate
Attorneys and Patent Profile Analytics
Cost/Value Curve of Patent a Portfolio
How Should IP be Considered for Acquisition?
What is a Patent Portfolio?
Licensing Density
Why Do You Enjoy Being a Lawyer?
How is the Entire Patent Considered Prior Art?
Limited Valuable Patents in Technology Area
Covered Business Method Review
Using Product Association with IP Assets
5 Year View Point
Claim Abstraction Theory
Determining Likelihood of Confusion
Freedom to Operate (FTO) Process
Patent Analytics and Competition
A Less Expensive Alternative
Circle "R"
Requirements to Receive a Patent
Impact of PTAB
The Advantage of Filing First
Soft Assets
4 Ways to Prepare your Patent Portfolio for Battle.
Merrifield Synthesis
Practicing an Invention
What is a BioSimilar?
Value Management and Cash Flow
Post-Grant Review
Patent Examination Process
Tools for Auditing a Patent Portfolio
Value Management and Risk Management
Technical Background
Joint Ventures and Dispute Resolution
Becoming a Patent Lawyer
Cited Art Landscape
Low Risk Joint Ventures
Patents and Practicing an Invention
Joint Venture Ground Rules
"Wheres" - Audit Action Sheet
Qualifying for a Patent
Demonstrating BioSimilarity Under U.S. Law
"Whens" - Audit Action Sheet
What Engineers Can Learn from Patent Profile Analytics
How is Schwegman Lundberg & Woessner Different?
Evaluation Agreement and Computer Codes
The Case of the Joint Marketing Agreement Gone Bad
Reasons to Consider Joint Ventures
Managing OSS
Unlicensed Source Codes
Steps to Obtaining a Patent
Benefits of Audit Action Sheet
NDAs and Computer Codes
Domain Registration Considerations
What Makes Schwegman, Lundberg & Woessner Different?
Patent Status Updates
Tracking Work History
Portfolio Dashboard - Inventor Information
Hiring Patent Council
What is Prior Art?
Types of Inventions That Are Patentable
Provisional Patent
Post-Grant Proceedings and Patent Enforcement
Litigation Density
Improperly Marked Product
By the Numbers Overview
Post-Grant Options and Cost
How Big Should My First Patent Be?
Trade Secrets
Geographic Insight and Patent Profile Analytics
Is A United States Registered Trademark Effective in Other Countries?
Approvals of BioSimilars in Europe
Purposes of a Trademark
Trade Names vs Trademarks
Portfolio Mapping
Risk Profile
Who Determines Substitution Factors?
Office Action
Patent Owner Rights
Post-Litigation Challenges
Am I Required to Search for Prior Art?
Intent of Patent Laws
Factors That Cause a Patent to Decline in Value
Confidential Information
Types of Intellectual Property Protection
Specimen
Assessing Executive Experience
Trademark
Merely Descriptive Refusal
Common Law Trademark Rights
Convergence Density
Establishing Confidentiality
Outside of Law
Consequences of a Poorly Drafted Patent
Biologics Price Competition and Innovation Act
Hard Assets
Two Main Value Drivers
Patent Profile Analytics and Managers
What is a BioSimilar Product Under US Law?
Confidential Information and Business Damage
Meet Mark Stignani
Proper Way to Use a Trademark
Interpretational Differences Between Prosecution and Litigation
Researching Competitors' IP
Joint Venture and Financial Agreements
Patent Profile Analytics and Researchers
What to Do When First Selecting a Mark
Schwegman Lundberg & Woessner & Post Grant Trial Practice
Forward Citation Landscape
Biologics vs Small Molecules
PTAB Timing Trial Dynamics
Inter Partes Review
Consequences of Disclosing Confidential Information
Schwegman, Lundberg & Woessner - Chemicals and Pharmaceuticals
Advantages of Registering a Trademark
Pre-Litigation Challenges
Mitigating Risks of Past Damages
Impact of Post-Grant Proceedings
Limiting Issues Defined in District Court
Discovering Annuity Information
When is a House like a Patent?
IP Registration Density
Categories of Marks
Claim Maps and BioSimilars
Moderate Risk Joint Ventures
Scope Concepts and Headnotes
Meet David Black
How Much Does it Cost to Get a Patent?
Patent Portfolio and Budgets/Spending
How Does the Knowledge Gap Worsen Over Time?
Post-Grant Options and Estoppel
Effective Stay Strategy
Wasting Money on Low-Value Patents
How Should IP be Considered for Growth?
What is a Trademark?
First Step in Performing a Patent Portfolio Audit
Process for Registering a Trademark in the United States
How Do Patent Portfolio Values Become Concentrated over Time?
Attributes of a Good Patent
Patent Citation Ranking
Different Parts of a Patent Document
Ideal Patent Strategy
Broad Patent Claim
Get Your Assignments Straight - Contribution of Owners
Importance of Post-Grant Proceedings
Unanticipated OSS
First Item on IP To-Do List
Freedom To Operate
Risks of OSS
How do Patent Prosecution Services Vary in Value?
Trademark Filing Considerations
Cost/Value Curve of a High Level Patent
Equal Value Patents
Downside of Static Budget Allocation for Patents
Helping In-House Council
Patent Ownership and Patent Profile Analytics
"TM" Symbol
Naming Problems with BioSimilars
Value Management Lifecycle
Non-Disclosure Agreement
Genericide
Litigation and BioSimilar Patenting
What Should a Company Understand at the End of an IP Audit?
Signing an NDA
Rebutting a Merely Descriptive Refusal
"Who" - Audit Action Sheet
How is Open Source Incorporated into Software?
Why Are Biologicals so Important?
Backward Citations
Renewing a Trademark Registration
Sponsor
Why Is Executing an NDA Not Enough?
Seeking Money from Investors
Most Common Client Question
Patent Profile Analytics and Engineers
Are BioSimilars Being Approved in the US?
Freedom to Operate
Calculating New Investments
Common Reasons Trademarks Are Rejected
Open Source Initiative
Standard for Getting a Patent
Traditional Re-Examination
Do Narrow Patents Add Value to a Portfolio?
What Does an Audit Action Sheet Look Like?
Patent Infringement
How Does the Knowledge Gap Develop?
Impact of US Hatch Waxman Act 1984
What Should a Company Patent?
How is Open Source Software Enforced?
Post-Grant Proceedings
"Whats" - Audit Action Sheet
Preventing "Genericide"
Importance of Freedom To Operate
Prior Art in Prosecution vs Prior Art in Litigation
Engineers Not Understanding Patents
Is There Still a Place for Traditional Re-Examination?
Raising Good Prosecution Visibility
How to Fix the Knowledge Gap
Post-Grant Options and Grounds of Challenge
Attorneys Not Understanding the Market
Joint Venture Pitfalls
How to Remedy Unwanted Disclosure of Confidential Information
Segmenting a Portfolio
Trade Dress
Independent Claim vs Dependent Claim
Patents 101
Post-Grant Options
Patent Strategy Considerations
Contractual Intellectual Property Rights
Important Attributes to Being a Successful Patent Lawyer
